IMR Press / EJGO / Volume 40 / Issue 1 / DOI: 10.12892/ejgo4417.2019
Open Access Case Report
Primary fallopian tube carcinoma - case report
Show Less
1 Medical faculty University of Belgrade, Belgrade, Serbia
2 Clinic of Obstetrics and Gynecology “Narodni Front”, Belgrade, Serbia
Eur. J. Gynaecol. Oncol. 2019, 40(1), 163–165; https://doi.org/10.12892/ejgo4417.2019
Published: 10 February 2019
Abstract

Primary fallopian tube carcinoma is a rare gynecological malignancy and it accounts for about 1% of all gynecological malignancies. Etiological factors are not sufficiently known, but most commonly specified are infertility, nulliparity, and pelvic inflammatory disorder. It is most often asymptomatic, although, a triad reported by Latzko including a vaginal watery discharge, colic like pelvic pain, presence of tumor mass in pelvis, is mentioned as pathognomonic. In the present case, it was primary fallopian tube carcinoma, in FIGO Stage IA. After complete abdominal hysterectomy with lymph node dissection, in line with the expert council’s decision, no adjuvant chemotherapy was administered. PET CT in June 2017, two years after the surgical treatment, presented both some metastatic changes in lungs and enlarged retroperitoneal lymph nodes and after this finding, and chemotherapy with carboplatin was begun. The therapy implies surgical treatment being hysterectomy with adnexectomy, but also retroperitoneal lymph node dissection as well, considering that it more often affects lymphatic glands than epithelial ovarian cancer (EOC). It can be misinterpreted with EOC in a pathological sense. In addition to a surgical treatment, the most common form of chemotherapy is platinum-combined with taxanes.

Keywords
Fallopian tube carcinoma
Epithelial ovarian cancer
Pelvic inflammatory disorder
Chemotherapy
Platinum
Taxanes
Figures
Figure 1.
Share
Back to top